Home Cart 0 Sign in  

[ CAS No. 54624-57-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 54624-57-6
Chemical Structure| 54624-57-6
Structure of 54624-57-6 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 54624-57-6 ]

Related Doc. of [ 54624-57-6 ]

Alternatived Products of [ 54624-57-6 ]

Product Details of [ 54624-57-6 ]

CAS No. :54624-57-6 MDL No. :MFCD00160009
Formula : C7H5BrN2 Boiling Point : -
Linear Structure Formula :- InChI Key :PHPYXVIHDRDPDI-UHFFFAOYSA-N
M.W : 197.03 Pubchem ID :2776281
Synonyms :

Calculated chemistry of [ 54624-57-6 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 43.79
TPSA : 28.68 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.88 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.33
Log Po/w (XLOGP3) : 2.28
Log Po/w (WLOGP) : 2.33
Log Po/w (MLOGP) : 1.75
Log Po/w (SILICOS-IT) : 2.75
Consensus Log Po/w : 2.09

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.16
Solubility : 0.135 mg/ml ; 0.000685 mol/l
Class : Soluble
Log S (Ali) : -2.52
Solubility : 0.596 mg/ml ; 0.00302 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.77
Solubility : 0.0337 mg/ml ; 0.000171 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.6

Safety of [ 54624-57-6 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 54624-57-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 54624-57-6 ]
  • Downstream synthetic route of [ 54624-57-6 ]

[ 54624-57-6 ] Synthesis Path-Upstream   1~8

  • 1
  • [ 54624-57-6 ]
  • [ 15108-18-6 ]
YieldReaction ConditionsOperation in experiment
91% Reflux The schematic representation of the synthesis of LHAc is given in Scheme 1. First, 2-bromobenzimidazole was obtained from 2-mercaptobenzimidazole by the reported method [13]. In the nextstep, 2-bromobenzimidazole (1.97 g, 0.01 mol) was refluxed in20 mL of 80percent hydrazine hydrate solution, to obtain 2-Hydrazinobenzimidazole (1.35 g, Yield: 91percent). Finally, diacetylmonoxime (1.01 g, 0.01 mol) was added to the 20 ml methanolicsolution of 2-hydrazinobenzimidazole (1.48 g, 0.01 mol) in presenceof 3 drops of glacial acetic acid. The resulting mixture wasrefluxed for 4 h. On cooling, the white crystals separated werefiltered and washed with cold methanol to get the desired product(1.6 g, yield: 55percent, M.P 240 C).
91% for 4 h; Reflux The schematic representation of the synthesis of ligand is given in Scheme 1 . First, 2-bromobenzimidazole was obtained from 2-mercaptobenzimidazole by the reported method [24]. In the next step, 2-bromobenzimidazole (1.97g, 10mmol) was refluxed in 20.0mL of 80percent hydrazine hydrate solution, to obtain 2-hydrazinobenzimidazole (1.35g, Yield: 91percent) [25]. Finally, to the magnetically stirred methanolic solution of 2-hydrazinobenzimidazole (1.65g, 10.0mmol), hydroxyacetone (0.740g, 10.0mmol) in methanol was added dropwise. The mixture was refluxed on a water bath for 1h. The progress of the reaction was monitored by TLC. The buff colored precipitate formed was filtered and washed with cold methanol. The solid product was dried in vacuo for 4h.
Reference: [1] Journal of Molecular Structure, 2017, vol. 1133, p. 546 - 556
[2] Polyhedron, 2017, vol. 127, p. 225 - 237
  • 2
  • [ 54624-57-6 ]
  • [ 2620-76-0 ]
Reference: [1] Patent: CN106967052, 2017, A,
[2] Patent: CN106946853, 2017, A,
[3] Patent: CN107417668, 2017, A,
  • 3
  • [ 134469-07-1 ]
  • [ 54624-57-6 ]
Reference: [1] Angewandte Chemie - International Edition, 2015, vol. 54, # 52, p. 15859 - 15862[2] Angew. Chem., 2015, vol. 127, # 52, p. 16085 - 16088,3
[3] Bioorganic and Medicinal Chemistry Letters, 2000, vol. 10, # 22, p. 2509 - 2512
[4] Journal of Molecular Structure, 2017, vol. 1133, p. 546 - 556
[5] Polyhedron, 2017, vol. 127, p. 225 - 237
[6] Journal of Medicinal Chemistry, 1992, vol. 35, # 4, p. 705 - 716
[7] Synthetic Communications, 2013, vol. 43, # 14, p. 1882 - 1895
[8] Chemistry - An Asian Journal, 2014, vol. 9, # 9, p. 2542 - 2547,6
[9] Bioorganic and Medicinal Chemistry, 2003, vol. 11, # 18, p. 3997 - 4002
  • 4
  • [ 95-54-5 ]
  • [ 54624-57-6 ]
Reference: [1] Journal of the Korean Chemical Society, 2010, vol. 54, # 5, p. 589 - 593
[2] Journal of the Chilean Chemical Society, 2012, vol. 57, # 2, p. 1122 - 1125,4
  • 5
  • [ 51-17-2 ]
  • [ 54624-57-6 ]
Reference: [1] Tetrahedron Letters, 1986, vol. 27, # 9, p. 1051 - 1054
  • 6
  • [ 934-32-7 ]
  • [ 54624-57-6 ]
Reference: [1] Organic Letters, 2017, vol. 19, # 10, p. 2518 - 2521
  • 7
  • [ 583-39-1 ]
  • [ 54624-57-6 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2010, vol. 18, # 5, p. 1918 - 1924
  • 8
  • [ 95-54-5 ]
  • [ 54624-57-6 ]
Reference: [1] Synthetic Communications, 2013, vol. 43, # 14, p. 1882 - 1895
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 54624-57-6 ]

Bromides

Chemical Structure| 50847-09-1

[ 50847-09-1 ]

2-Bromo-1H-imidazole-4,5-dicarbonitrile

Similarity: 0.76

Chemical Structure| 23328-88-3

[ 23328-88-3 ]

2-Bromo-4-methyl-1H-imidazole

Similarity: 0.75

Chemical Structure| 1388031-41-1

[ 1388031-41-1 ]

2-Bromo-6-chloro-1H-benzo[d]imidazole

Similarity: 0.72

Chemical Structure| 83741-35-9

[ 83741-35-9 ]

4-Bromo-1H-benzoimidazole

Similarity: 0.71

Chemical Structure| 791595-74-9

[ 791595-74-9 ]

5-Bromo-1H-benzo[d]imidazol-2-amine

Similarity: 0.69

Related Parent Nucleus of
[ 54624-57-6 ]

Benzimidazoles

Chemical Structure| 1632-83-3

[ 1632-83-3 ]

1-Methylbenzimidazole

Similarity: 0.73

Chemical Structure| 1388031-41-1

[ 1388031-41-1 ]

2-Bromo-6-chloro-1H-benzo[d]imidazole

Similarity: 0.72

Chemical Structure| 17228-38-5

[ 17228-38-5 ]

N-Methyl-1H-benzo[d]imidazol-2-amine

Similarity: 0.71

Chemical Structure| 83741-35-9

[ 83741-35-9 ]

4-Bromo-1H-benzoimidazole

Similarity: 0.71

Chemical Structure| 582-60-5

[ 582-60-5 ]

5,6-Dimethyl-1H-benzo[d]imidazole

Similarity: 0.70